ZNTL - Zentalis Pharmaceuticals Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Current Price & Safety Score Price: 2.07 USD StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): -8.80 StockBond Score: -5.26 Company Description Zentalis Pharmaceuticals Inc is a clinicalstage biopharmaceutical company which engages in discovering and developing clinically differentiated novel small molecule therapeutics targeting fundamental biological pathways of cancer It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations The company was founded by Kevin D Bunker and Cam Gallagher on December 23 2014 and is headquartered in San Diego CA